Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT03497637

Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses

Led by Helios Health Institute GmbH · Updated on 2024-11-25

1054

Participants Needed

8

Research Sites

314 weeks

Total Duration

On this page

Sponsors

H

Helios Health Institute GmbH

Lead Sponsor

H

Heart Center Leipzig - University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a prospective, randomized, controlled, multicenter, open-label study designed to assess whether vFFR is non-inferior to FFR in assessment of intermediate coronary stenosis in terms of the occurrence of MACE during 12 months after randomization.

CONDITIONS

Official Title

Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age >18 years
  • Willing and able to understand, read, and sign informed consent before the procedure
  • Eligible for coronary angiography and/or PCI
  • Coronary artery disease in one or more native major epicardial vessels or branches with visually assessed new coronary stenosis of uncertain severity (typically 40-80% diameter narrowing)
  • Stable angina or acute coronary syndrome (only in non-culprit vessels and outside primary intervention during acute STEMI or NSTE-ACS)
  • Participation in another interventional study
Not Eligible

You will not qualify if you...

  • Previous coronary artery bypass graft surgery with patent grafts to the studied vessel
  • Tandem stenoses more than 10 mm apart requiring separate pressure wire assessment or PCI
  • Complete coronary artery occlusions
  • Hemodynamic instability classified as Killip class III-IV
  • Very calcified or twisted vessels
  • Terminal illness with life expectancy under 12 months
  • STEMI within 48 hours before procedure
  • Severe valvular heart disease
  • Acute coronary syndrome patients with unclear culprit lesion
  • Significant contraindications to adenosine (e.g., asthma)
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

Heart Center Dresden - University Clinic

Dresden, Germany

Actively Recruiting

2

University Clinic Erlangen

Erlangen, Germany

Actively Recruiting

3

Universitätsklinikum Essen

Essen, Germany, 45147

Actively Recruiting

4

University Clinic Giessen and Marburg

Giessen, Germany

Actively Recruiting

5

Herzzentrum Leipzig

Leipzig, Germany

Actively Recruiting

6

University Clinic Leipzig

Leipzig, Germany

Actively Recruiting

7

Klinikum der Stadt Ludwigshafen

Ludwigshafen, Germany

Actively Recruiting

8

Lukaskrankenhaus Neuss

Neuss, Germany

Actively Recruiting

Loading map...

Research Team

H

Holger Thiele, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here